General Hospital of PLA
Beijing, Beijing Municipality, China
Location status: Recruiting
NCT Number: NCT06791447
This is a multi-center, clinical study designed to evaluate the application and effectiveness of an AI-assisted predictive model for outcome of dialysis patients, leveraging multimodal health data.
Interested in participating?
Request Info20 year–100 year
All sexes
Observational
Beijing, Beijing Municipality, China
Location status: Recruiting
This study aims to develop an AI-assisted model to predict clinical outcomes in dialysis patients, focusing on both primary outcomes (e.g., mortality) and intermediate outcomes (e.g., anemia, blood pressure, nutritional status, and calcium-phosphate metabolism). The study will utilize patients' EHR data, including laboratory test results, medical history, dialysis treatment information, and clinical observations, to predict these health outcomes. The goal is to improve early identification of at-risk patients, enabling better clinical decision-making and personalized care strategies.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This study utilizes an AI-assisted predictive model that analyzes multimodal data from electronic health records, including medical history, laboratory results, dialysis treatment details, and clinical observations, to predict outcomes for dialysis patients. The model employs deep learning algorithms to predict mortality risk, intermediate outcomes such as anemia, blood pressure control, nutrition, and calcium-phosphate metabolism, and helps identify early signs of deterioration. The intervention is not a direct treatment or procedure but aims to develop a tool for predicting patient outcomes and optimizing treatment strategies to improve overall health and survival rates for dialysis patients.
Time frame: 1 year
The ability of the AI-assisted predictive model to accurately predict the risk of mortality in dialysis patients. Prediction accuracy will be assessed using the Area Under the Curve (AUC), F1 score, and sensitivity/specificity. The model will be evaluated by comparing the predicted mortality risk with actual outcomes (i.e., whether patients survived or passed away during the study period).
Time frame: 1 year
The accuracy of the AI-assisted predictive model in forecasting complications commonly experienced by dialysis patients, including anemia, uncontrolled blood pressure, poor nutritional status, and abnormalities in calcium-phosphate metabolism. The model's performance will be assessed using metrics such as AUC, F1 score, and accuracy by comparing predicted values to actual clinical outcomes, such as lab results, clinical diagnoses, and patient health status.
Contact information is provided by the study sponsor or research team.
The Eye Hospital of Wenzhou Medical University
Other
Predicting Clinical Outcomes in Dialysis Patients Using Electronic Health Records: An AI-Based Approach
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07561424
Dialysis Patients, ESKD
Paris, France
View Trial DetailsNCT07106151
AKI, AKI - Acute Kidney Injury
San Francisco, California, United States
View Trial DetailsNCT07269379
Chronic Disease, Dialysis Patients
Strasbourg, France
View Trial DetailsNCT07326306
Dialysis Patients
Van, Turkey (Türkiye)
View Trial Details